Organization
University of Cambridge
4 clinical trials
8 abstracts
Clinical trial
A Randomised Phase II Double-blinded Placebo-controlled Trial of Intravenous Immunoglobulins and Rituximab in Patients With Antibody-associated Psychosis (SINAPPS2)Status: Recruiting, Estimated PCD: 2026-03-31
Abstract
Characterizing disparities in receipt of palliative care for Asian Americans, Native Hawaiians, and Pacific Islanders with metastatic cancer in the United States.Org: University of Cambridge,
Clinical trial
Research Evaluating Sports ConcUssion Events - Rapid Assessment of Concussion and Evidence for ReturnStatus: Completed, Estimated PCD: 2020-12-31
Clinical trial
The NeuralNET: Research to Impact Diagnosis, Mechanistic Understanding and Treatment of Children's Brain and Mental Health Disorders - A Pilot Study in Cerebral PalsyStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
PET Imaging of Inflammation and Lipid Lowering StudyStatus: Recruiting, Estimated PCD: 2025-03-01
Abstract
Prediction of cancer treatment response from histopathology images through imputed transcriptomics.Org: Pangea Biomed, University of Pittsburgh, Pittsburgh, PA, Sheba Medical Center at Tel-Hashomer, University of Colorado School of Medicine, Department of Oncology and Cancer Research UK Cambridge Institute,
Abstract
SMALL: Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer—A UK phase III randomised multi-centre trial.Org: Queen's University Belfast, University of Cambridge, University of Oxford, Western General Hospital, University of Birmingham,
Abstract
ANALYSES OF PLASMA METABOLIC PROTEINS REVEAL BIOMARKERS PREDICTIVE OF SUBSEQUENT DEVELOPMENT OF GIANT CELL ARTERITIS; A PROSPECTIVE STUDYOrg: Lund University, Academic Specialist Center, Center for Rheumatology, Stockholm, Sweden, University of Gothenburg, Skåne University Hospital, Lund University, University of Cambridge,
Abstract
A phase iii randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active class iii or iv lupus nephritisOrg: Northwell Health, New Hyde Park, NY, University of North Carolina at Chapel Hill, University of California San Francisco, Keio University School of Medicine, Hospital Fernández,
Abstract
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY OF AVACOPAN IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITISOrg: University of Pennsylvania, University of Cambridge, ChemoCentryx, Inc.,
Abstract
Belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: effect on biomarkersOrg: University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, UK University Hospital Gasthuisberg, Leuven Cancer Institute, Belgium Botnar Research Centre,
Abstract
BILAG-2004 INDEX: A RELIABLE TOOL FOR ASSESSMENT OF SLE ACTIVITYOrg: University of Birmingham, Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, University College London, London, United Kingdom, University College London, Centre for Rheumatology, Division of Medicine, London, United Kingdom, MRC Biostatistic Unit, University of Cambridge,